Multicenter Canadian phase III randomized trial of 3 months vs 8 months neoadjuvant androgen deprivation prior to conventional dose radiotherapy for clinically localized prostate cancer

被引：0
|
作者：
Crook, JM
Ludgate, C
Lim, J
Malone, S
Eapen, L
Perry, G
Bowen, J
Robertson, S
Lockwood, G
机构：
来源：
JOURNAL OF UROLOGY | 2004年 / 171卷 / 04期
关键词：
D O I：
10.1016/S0022-5347(18)38419-2
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：312 / 312
页数：1
相关论文
共 50 条
  • [1] Report of a multicenter canadian phase III randomized trial of 3 months vs. 8 months neoadjuvant androgen deprivation before standard-dose radiotherapy for clinically localized prostate cancer
    Crook, J
    Ludgate, C
    Malone, S
    Lim, J
    Perry, G
    Eapen, L
    Bowen, J
    Robertson, S
    Lockwood, G
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2004, 60 (01): : 15 - 23
  • [2] FINAL REPORT OF MULTICENTER CANADIAN PHASE III RANDOMIZED TRIAL OF 3 VERSUS 8 MONTHS OF NEOADJUVANT ANDROGEN DEPRIVATION THERAPY BEFORE CONVENTIONAL-DOSE RADIOTHERAPY FOR CLINICALLY LOCALIZED PROSTATE CANCER
    Crook, Juanita
    Ludgate, Charles
    Malone, Shawn
    Perry, Gad
    Eapen, Libni
    Bowen, Julie
    Robertson, Susan
    Lockwood, Gina
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2009, 73 (02): : 327 - 333
  • [3] Report of a multicentre Canadian phase III randomized trial of three months versus eight months neoadjuvant androgen deprivation prior to standard dose radiotherapy for clinically localized prostate cancer
    Crook, J.
    Ludgate, C.
    Malone, S.
    Lim, J.
    Eapen, L.
    Bowen, J.
    Lockwood, G.
    RADIOTHERAPY AND ONCOLOGY, 2007, 84 : S11 - S11
  • [4] Final report of a Canadian phase III trial of 3 vs 8 months Neoadjuvant androgen deprivation prior to 66 gray external beam radiotherapy for clinically localized prostate cancer
    Crook, J. M.
    Ludgate, C.
    Malone, S.
    Eapen, L.
    Perry, G.
    Bowen, J.
    Robertson, S.
    Lockwood, G.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2008, 72 (01): : S75 - S75
  • [5] Timing of androgen-deprivation therapy and radical radiotherapy in localized prostate cancer: a phase III randomized controlled trial
    Nieder, Carsten
    STRAHLENTHERAPIE UND ONKOLOGIE, 2020, 196 (08) : 738 - 739
  • [6] Phase II study of neoadjuvant androgen deprivation followed by external-beam radiotherapy with 9 months of androgen deprivation for intermediate- to high-risk localized prostate cancer
    Heymann, Jonas J.
    Benson, Mitchell C.
    O'Toole, Kathleen M.
    Malyszko, Bozena
    Brody, Rachel
    Vecchio, Darleen
    Schiff, Peter B.
    Mansukhani, Mahesh M.
    Ennis, Ronald D.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (01) : 77 - 84
  • [7] Dose escalated external beam radiotherapy versus neoadjuvant androgen deprivation therapy and conventional dose external beam radiotherapy for clinically localized prostate cancer: Do we need both?
    Roach, Mack
    STRAHLENTHERAPIE UND ONKOLOGIE, 2007, 183 (Suppl 2) : 26 - 28
  • [8] Dose Escalated External Beam Radiotherapy versus Neoadjuvant Androgen Deprivation Therapy and Conventional Dose External Beam Radiotherapy for Clinically Localized Prostate Cancer: Do we Need Both?
    Mack Roach
    Strahlentherapie und Onkologie, 2007, 183 : 26 - 28
  • [9] The role of hemoglobin concentration in clinically localized prostate cancer treated with radical radiotherapy ±neoadjuvant androgen deprivation
    Parker, C
    Warde, P
    Norman, A
    Panzarella, T
    Catton, C
    Horwich, A
    Huddart, R
    Dearnaley, D
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2004, 58 (01): : 53 - 58
  • [10] Re: Androgen deprivation therapy and radiotherapy in intermediate risk prostate cancer: A randomized phase III trial
    Guler, Ozan Cem
    Onal, Cem
    EUROPEAN JOURNAL OF CANCER, 2022, 167 : 164 - 165
12345